Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study. (Q54072278)

24 May 2018

title

Intravenous prostacyclin mitigates inhaled nitric oxide rebound effect: A case control study. (English)

1 reference

24 May 2018

author name string

Hermon M

1

1 reference

24 May 2018

Golej J

2

1 reference

24 May 2018

Burda G

3

1 reference

24 May 2018

Marx M

4

1 reference

24 May 2018

Trittenwein G

5

1 reference

24 May 2018

Pollak A

6

1 reference

24 May 2018

publication date

1 November 1999

1 reference

24 May 2018

published in

Artificial Organs

1 reference

24 May 2018

volume

23

1 reference

24 May 2018

issue

11

1 reference

24 May 2018

page(s)

975-978

1 reference

24 May 2018

Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass.

cites work

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Inhaled nitric oxide in congenital heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Inhaled nitric oxide in the treatment of postoperative graft dysfunction after lung transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Rebound Hemodynamic Events after the Abrupt Withdrawal of Nitroprusside in Patients with Severe Chronic Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Cardiac performance in ECMO candidates: echocardiographic predictors for ECMO

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Rebound pulmonary hypertension after inhalation of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Pulmonary hypertensive crises following surgery for congenital heart defects in young children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Comparison of the haemodynamic effects of epoprostenol (prostacyclin) and tolazoline

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Adventures and excursions in bioassay—the stepping stones to prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1525-1863.1999.06448.X

10.1046/J.1525-1863.1999.06448.X

21 January 2018

Identifiers

DOI

1 reference

24 May 2018

1 reference

24 May 2018